ISO/TS 5798:2022

In vitro diagnostic test systems — Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods

Publication date: 19 pri 2022

General information

Current stage: 90.20 Effective date: 15 pri 2025

Originator: ISO

Owner: ISO/TC 212

Type: Technical Specification

ICS: 11.100.01

Gjuha: anglisht frëngjisht

Buying

Statusi: Publikuar

PDF - 20 013 Lekë

Paper - 20 013 Lekë

CD - 20 013 Lekë

Language

Language in which you want to receive the document.

Scope

This document provides requirements and recommendations for the design, development, verification, validation and implementation of analytical tests for detecting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using nucleic acid amplification. It addresses pre-examination, examination and post-examination process steps for human specimens.
This document is applicable to medical laboratories. It is also intended to be used by in vitro diagnostic developers and manufacturers, as well as by institutions and organizations supporting SARS-CoV-2 research and diagnostics.
This document does not apply to environmental samples.

Life cycle

NOW

PUBLISHED
ISO/TS 5798:2022
90.20 Standard under periodical review
15 pri 2025

Preview

Vetëm seksionet informative të projekteve janë në dispozicion të publikut. Për të parë përmbajtjen e plotë, do t'ju duhet të krijoni një llogari. Nëse jeni anëtar, ju lutemi hyni në llogarinë tuaj duke klikuar në butonin "Identifikohu".